The study from the American Society of Clinical Oncology (ASCO) found that states that expanded Medicaid saw a 29 percent drop in cancer deaths, compared to a 25 percent drop for states that did not.
“This is the first study to show the benefit of Medicaid expansion on cancer death rates on a national scale,” said Anna Lee, who is the lead author and radiation oncology fellow at Memorial Sloan Kettering Cancer Center (MSK) in New York. “We now have evidence that Medicaid expansion has saved the lives of many people with cancer across the United States.” Continue reading.